공지 • Mar 24
Norofert S.A., Annual General Meeting, Apr 29, 2026 Norofert S.A., Annual General Meeting, Apr 29, 2026. 공지 • Feb 25
Norofert S.A. (BVB:NRF) agreed to acquire 60% stake in Expert Agribusiness Srl on February 23, 2026. Norofert S.A. (BVB:NRF) entered into an agreement to acquire 60% stake in Expert Agribusiness Srl on February 23, 2026.
The transaction amounted to €0.1 million. The full amount will be paid by December 2026. Reported Earnings • Nov 27
Third quarter 2025 earnings released Third quarter 2025 results: Revenue: RON14.5m (down 4.7% from 3Q 2024). Net income: RON1.38m (up RON1.85m from 3Q 2024). Profit margin: 9.5% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses. Reported Earnings • Sep 26
Second quarter 2025 earnings released Second quarter 2025 results: Revenue: RON7.17m (down 36% from 2Q 2024). Net loss: RON4.59m (down 348% from profit in 2Q 2024). Valuation Update With 7 Day Price Move • Jul 16
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to RON3.94, the stock trades at a trailing P/E ratio of 8x. Average trailing P/E is 21x in the Chemicals industry in Europe. Negligible returns to shareholders over past year. Reported Earnings • May 29
First quarter 2025 earnings released First quarter 2025 results: Revenue: RON14.0m (up 20% from 1Q 2024). Net income: RON5.35m (up RON5.34m from 1Q 2024). Profit margin: 38% (up from 0% in 1Q 2024). The increase in margin was primarily driven by lower expenses. Valuation Update With 7 Day Price Move • May 23
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to RON3.69, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 18x in the Chemicals industry in Europe. Total loss to shareholders of 13% over the past year. New Risk • May 10
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: RON45.4m (US$9.98m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Earnings have declined by 26% per year over the past 5 years. Market cap is less than US$10m (RON45.4m market cap, or US$9.98m). New Risk • Apr 23
New major risk - Revenue and earnings growth Earnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.1x net interest cover). Earnings have declined by 26% per year over the past 5 years. Minor Risk Market cap is less than US$100m (RON48.5m market cap, or US$11.1m). New Risk • Apr 22
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 0% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (0% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (RON48.5m market cap, or US$11.1m). Reported Earnings • Apr 14
Full year 2024 earnings released: EPS: RON0.19 (vs RON0.23 loss in FY 2023) Full year 2024 results: EPS: RON0.19 (up from RON0.23 loss in FY 2023). Revenue: RON52.6m (up 19% from FY 2023). Net income: RON3.24m (up RON7.19m from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. 공지 • Mar 31
Norofert S.A., Annual General Meeting, May 05, 2025 Norofert S.A., Annual General Meeting, May 05, 2025. Reported Earnings • Dec 01
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: RON15.3m (up 11% from 3Q 2023). Net loss: RON473.8k (loss narrowed 76% from 3Q 2023). Reported Earnings • Oct 03
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: RON11.2m (up 30% from 2Q 2023). Net income: RON1.85m (up 29% from 2Q 2023). Profit margin: 17% (in line with 2Q 2023). Reported Earnings • Jun 04
First quarter 2024 earnings released First quarter 2024 results: Revenue: RON11.7m (down 14% from 1Q 2023). Net income: RON1.4k (down 100% from 1Q 2023). Profit margin: 0% (down from 12% in 1Q 2023). The decrease in margin was driven by lower revenue. Board Change • May 02
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. No independent directors (3 non-independent directors). Non-Executive Director Marian Alexe was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.